These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 15892667

  • 1. Pharmaceutical design of antimitotic agents based on combretastatins.
    Hsieh HP, Liou JP, Mahindroo N.
    Curr Pharm Des; 2005; 11(13):1655-77. PubMed ID: 15892667
    [Abstract] [Full Text] [Related]

  • 2. Isolation, structure, synthesis, and antimitotic properties of combretastatins B-3 and B-4 from Combretum caffrum.
    Pettit GR, Singh SB, Schmidt JM, Niven ML, Hamel E, Lin CM.
    J Nat Prod; 1988; 51(3):517-27. PubMed ID: 3404149
    [Abstract] [Full Text] [Related]

  • 3. Discovery, synthesis, activities, structure-activity relationships, and clinical development of combretastatins and analogs as anticancer drugs. A comprehensive review.
    Singh SB.
    Nat Prod Rep; 2024 Feb 21; 41(2):298-322. PubMed ID: 38009216
    [Abstract] [Full Text] [Related]

  • 4. Antineoplastic agents. 291. Isolation and synthesis of combretastatins A-4, A-5, and A-6(1a).
    Pettit GR, Singh SB, Boyd MR, Hamel E, Pettit RK, Schmidt JM, Hogan F.
    J Med Chem; 1995 May 12; 38(10):1666-72. PubMed ID: 7752190
    [Abstract] [Full Text] [Related]

  • 5. Synthesis and evaluation of double bond substituted combretastatins.
    Hadfield JA, Gaukroger K, Hirst N, Weston AP, Lawrence NJ, McGown AT.
    Eur J Med Chem; 2005 Jun 12; 40(6):529-41. PubMed ID: 15922837
    [Abstract] [Full Text] [Related]

  • 6. Combretastatins: from natural products to drug discovery.
    Cirla A, Mann J.
    Nat Prod Rep; 2003 Dec 12; 20(6):558-64. PubMed ID: 14700199
    [Abstract] [Full Text] [Related]

  • 7. Synthesis and biological activity of mustard derivatives of combretastatins.
    Coggiola B, Pagliai F, Allegrone G, Genazzani AA, Tron GC.
    Bioorg Med Chem Lett; 2005 Aug 01; 15(15):3551-4. PubMed ID: 15963722
    [Abstract] [Full Text] [Related]

  • 8. Cytotoxic Stilbenes and Derivatives as Promising Antimitotic Leads for Cancer Therapy.
    Faustino C, Francisco AP, Isca VMS, Duarte N.
    Curr Pharm Des; 2018 Aug 01; 24(36):4270-4311. PubMed ID: 30636588
    [Abstract] [Full Text] [Related]

  • 9. Combretastatins: An Overview of Structure, Probable Mechanisms of Action and Potential Applications.
    Karatoprak GŞ, Küpeli Akkol E, Genç Y, Bardakci H, Yücel Ç, Sobarzo-Sánchez E.
    Molecules; 2020 May 31; 25(11):. PubMed ID: 32486408
    [Abstract] [Full Text] [Related]

  • 10. The Use of Stilbene Scaffold in Medicinal Chemistry and Multi- Target Drug Design.
    Giacomini E, Rupiani S, Guidotti L, Recanatini M, Roberti M.
    Curr Med Chem; 2016 May 31; 23(23):2439-89. PubMed ID: 27183980
    [Abstract] [Full Text] [Related]

  • 11. Combretastatin dinitrogen-substituted stilbene analogues as tubulin-binding and vascular-disrupting agents.
    Siles R, Ackley JF, Hadimani MB, Hall JJ, Mugabe BE, Guddneppanavar R, Monk KA, Chapuis JC, Pettit GR, Chaplin DJ, Edvardsen K, Trawick ML, Garner CM, Pinney KG.
    J Nat Prod; 2008 Mar 31; 71(3):313-20. PubMed ID: 18303849
    [Abstract] [Full Text] [Related]

  • 12. Synthesis and cytotoxic evaluation of combretafurans, potential scaffolds for dual-action antitumoral agents.
    Pirali T, Busacca S, Beltrami L, Imovilli D, Pagliai F, Miglio G, Massarotti A, Verotta L, Tron GC, Sorba G, Genazzani AA.
    J Med Chem; 2006 Aug 24; 49(17):5372-6. PubMed ID: 16913727
    [Abstract] [Full Text] [Related]

  • 13. The biology of the combretastatins as tumour vascular targeting agents.
    Tozer GM, Kanthou C, Parkins CS, Hill SA.
    Int J Exp Pathol; 2002 Feb 24; 83(1):21-38. PubMed ID: 12059907
    [Abstract] [Full Text] [Related]

  • 14. Synthesis of biologically active polyphenolic glycosides (combretastatin and resveratrol series).
    Orsini F, Pelizzoni F, Bellini B, Miglierini G.
    Carbohydr Res; 1997 Jun 20; 301(3-4):95-109. PubMed ID: 9232838
    [Abstract] [Full Text] [Related]

  • 15. Combretastatin A-4 analogues as antimitotic antitumor agents.
    Nam NH.
    Curr Med Chem; 2003 Sep 20; 10(17):1697-722. PubMed ID: 12871118
    [Abstract] [Full Text] [Related]

  • 16. Synthesis and anti-tumor activity of novel combretastatins: combretocyclopentenones and related analogues.
    Nam NH, Kim Y, You YJ, Hong DH, Kim HM, Ahn BZ.
    Bioorg Med Chem Lett; 2002 Aug 05; 12(15):1955-8. PubMed ID: 12113817
    [Abstract] [Full Text] [Related]

  • 17. A new approach to combretastatin D2.
    Cousin D, Mann J, Nieuwenhuyzen M, van den Berg H.
    Org Biomol Chem; 2006 Jan 07; 4(1):54-62. PubMed ID: 16357997
    [Abstract] [Full Text] [Related]

  • 18. [Natural organic compounds that affect to microtubule functions: syntheses and structure-activity relationships of combretastatins, curacin A and their analogs as the colchicine-site ligands on tubulin].
    Iwasaki S, Shirai R.
    Yakugaku Zasshi; 2000 Oct 07; 120(10):875-89. PubMed ID: 11082700
    [Abstract] [Full Text] [Related]

  • 19. Recent advancement in discovery and development of natural product combretastatin-inspired anticancer agents.
    Patil PO, Patil AG, Rane RA, Patil PC, Deshmukh PK, Bari SB, Patil DA, Naphade SS.
    Anticancer Agents Med Chem; 2015 Oct 07; 15(8):955-69. PubMed ID: 26007283
    [Abstract] [Full Text] [Related]

  • 20. Combretastatins: In vitro structure-activity relationship, mode of action and current clinical status.
    Jaroch K, Karolak M, Górski P, Jaroch A, Krajewski A, Ilnicka A, Sloderbach A, Stefański T, Sobiak S.
    Pharmacol Rep; 2016 Dec 07; 68(6):1266-1275. PubMed ID: 27686966
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.